Skip to content

Using nicotine patches to support smoking cessation among adolescents.

The effectiveness of Nicotine Replacement Therapy for young people aged 12 to 18 years.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22696
Enrollment
360
Registered
2011-08-22
Start date
2011-01-31
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking adolescents. Jongeren die roken.

Interventions

One week before starting the treatment period participants will attend a meeting where they will receive information about this study, a short behavioural intervention aiming at quitting smoking and i

Sponsors

Utrecht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Not having a major physical health problem; 2. Smoking at least 7 cigarettes a day; 3. Having parents who are aware of their smoking behavior; 4. Motivated to quit smoking; 5. Aged from 12 up to and including 18 years.

Exclusion criteria

Exclusion criteria: 1. Pregnancy, lactation; 2. Chronic skin conditions; 3. Current use of NRT or other smoking cessation medication (e.g. bupropion and Chantix); 4. Hypersensitivity to any ingredients in the patches.

Design outcomes

Primary

MeasureTime frame
The main primary endpoint will be prolonged abstinence 6 months after the quit date. In addition, the co-primary endpoint is abstinence 12 months after the quit date.

Secondary

MeasureTime frame
A first secondary endpoint includes mediating effects of changes in nicotine dependence symptoms, craving, withdrawal symptoms, negative affect, hunger, and perceived self-efficacy. Also, we will check for possible moderating effects of demographic characteristics (e.g. age, gender, educational level, and ethnicity) and smoking characteristics (e.g. severity of nicotine dependence, number of cigarettes a day).

Contacts

Public ContactCharlotte Scherphof

Postbus 80.140 3508 TC Utrecht

c.s.scherphof@uu.nl+31 (0)30 2533056

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)